(MORN) Morningstar - Ratings and Ratios
Data, Analytics, Ratings, Portfolios, Retirement
Dividends
| Dividend Yield | 0.83% |
| Yield on Cost 5y | 0.93% |
| Yield CAGR 5y | 1.69% |
| Payout Consistency | 95.9% |
| Payout Ratio | 18.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 22.6% |
| Value at Risk 5%th | 35.1% |
| Relative Tail Risk | -5.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.91 |
| Alpha | -50.66 |
| CAGR/Max DD | -0.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.446 |
| Beta | 0.839 |
| Beta Downside | 0.933 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.82% |
| Mean DD | 12.54% |
| Median DD | 8.71% |
Description: MORN Morningstar October 30, 2025
Morningstar, Inc. (NASDAQ:MORN) is a global provider of independent investment research and data, operating across North America, Europe, Asia-Pacific and other regions. The firm’s business is organized into five primary segments: Morningstar Data & Analytics, PitchBook, Morningstar Wealth, Morningstar Credit, and Morningstar Retirement, each delivering subscription-based software, research, and managed-investment products such as mutual funds, ETFs, and model portfolios.
Key growth levers include the rapid expansion of private-market data via PitchBook (which has seen double-digit annual revenue growth, driven by heightened venture-capital and private-equity activity) and the increasing demand for ESG and sustainability analytics supplied by Sustainalytics. In FY 2024, Morningstar reported subscription revenue of roughly $1.1 billion, representing about 78 % of total revenue, and a trailing-12-month operating margin of ~ 15 %, reflecting the high-margin nature of its SaaS-centric model. The company’s exposure to macro-drivers such as interest-rate cycles (affecting credit-rating services) and discretionary investment spending (impacting wealth-management tools) adds a layer of cyclicality to its earnings.
For a deeper dive into Morningstar’s valuation metrics, the ValueRay platform offers a granular, data-driven view of its financials and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (376.0m TTM) > 0 and > 6% of Revenue (6% = 143.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -1.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.41% (prev 5.71%; Δ -4.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 539.1m > Net Income 376.0m (YES >=105%, WARN >=100%) |
| Net Debt (568.4m) to EBITDA (729.4m) ratio: 0.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (42.6m) change vs 12m ago -1.39% (target <= -2.0% for YES) |
| Gross Margin 60.93% (prev 60.91%; Δ 0.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.25% (prev 62.33%; Δ 4.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.69 (EBITDA TTM 729.4m / Interest Expense TTM 39.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.06
| (A) 0.01 = (Total Current Assets 979.2m - Total Current Liabilities 945.5m) / Total Assets 3.56b |
| (B) 0.59 = Retained Earnings (Balance) 2.11b / Total Assets 3.56b |
| (C) 0.15 = EBIT TTM 538.2m / Avg Total Assets 3.56b |
| (D) 1.00 = Book Value of Equity 2.04b / Total Liabilities 2.04b |
| Total Rating: 4.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.42
| 1. Piotroski 7.0pt |
| 2. FCF Yield 4.11% |
| 3. FCF Margin 16.45% |
| 4. Debt/Equity 0.69 |
| 5. Debt/Ebitda 0.78 |
| 6. ROIC - WACC (= 8.55)% |
| 7. RoE 23.66% |
| 8. Rev. Trend 98.34% |
| 9. EPS Trend 57.88% |
What is the price of MORN shares?
Over the past week, the price has changed by +1.56%, over one month by +2.66%, over three months by -15.00% and over the past year by -38.49%.
Is MORN a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MORN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 278.3 | 27.6% |
| Analysts Target Price | 278.3 | 27.6% |
| ValueRay Target Price | 186.8 | -14.4% |
MORN Fundamental Data Overview December 02, 2025
P/E Trailing = 24.4437
P/E Forward = 19.0476
P/S = 3.7832
P/B = 5.8369
Beta = 1.112
Revenue TTM = 2.40b USD
EBIT TTM = 538.2m USD
EBITDA TTM = 729.4m USD
Long Term Debt = 848.9m USD (from longTermDebt, last quarter)
Short Term Debt = 39.9m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 568.4m USD (from netDebt column, last quarter)
Enterprise Value = 9.59b USD (9.06b + Debt 1.04b - CCE 514.5m)
Interest Coverage Ratio = 13.69 (Ebit TTM 538.2m / Interest Expense TTM 39.3m)
FCF Yield = 4.11% (FCF TTM 394.1m / Enterprise Value 9.59b)
FCF Margin = 16.45% (FCF TTM 394.1m / Revenue TTM 2.40b)
Net Margin = 15.70% (Net Income TTM 376.0m / Revenue TTM 2.40b)
Gross Margin = 60.93% ((Revenue TTM 2.40b - Cost of Revenue TTM 935.9m) / Revenue TTM)
Gross Margin QoQ = 60.85% (prev 61.89%)
Tobins Q-Ratio = 2.70 (Enterprise Value 9.59b / Total Assets 3.56b)
Interest Expense / Debt = 0.90% (Interest Expense 9.40m / Debt 1.04b)
Taxrate = 25.53% (31.4m / 123.0m)
NOPAT = 400.8m (EBIT 538.2m * (1 - 25.53%))
Current Ratio = 1.04 (Total Current Assets 979.2m / Total Current Liabilities 945.5m)
Debt / Equity = 0.69 (Debt 1.04b / totalStockholderEquity, last quarter 1.51b)
Debt / EBITDA = 0.78 (Net Debt 568.4m / EBITDA 729.4m)
Debt / FCF = 1.44 (Net Debt 568.4m / FCF TTM 394.1m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.57% (Net Income 376.0m / Total Assets 3.56b)
RoE = 23.66% (Net Income TTM 376.0m / Total Stockholder Equity 1.59b)
RoCE = 22.08% (EBIT 538.2m / Capital Employed (Equity 1.59b + L.T.Debt 848.9m))
RoIC = 16.79% (NOPAT 400.8m / Invested Capital 2.39b)
WACC = 8.24% (E(9.06b)/V(10.10b) * Re(9.11%) + D(1.04b)/V(10.10b) * Rd(0.90%) * (1-Tc(0.26)))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.47%
[DCF Debug] Terminal Value 75.67% ; FCFE base≈414.0m ; Y1≈445.9m ; Y5≈548.6m
Fair Price DCF = 192.2 (DCF Value 7.90b / Shares Outstanding 41.1m; 5y FCF grow 8.65% → 3.0% )
EPS Correlation: 57.88 | EPS CAGR: 19.93% | SUE: 0.44 | # QB: 0
Revenue Correlation: 98.34 | Revenue CAGR: 8.03% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.51 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=10.79 | Chg30d=+0.350 | Revisions Net=+1 | Growth EPS=+14.8% | Growth Revenue=+7.5%
Additional Sources for MORN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle